B · Normal
[AI pharmaceutical concept was active at the beginning of the trading session, Hongbo Pharmaceutical reached its daily limit of 20cm] On October 16, the AI ​​pharmaceutical concept was active at the beginning of the trading session. Hongbo Pharmaceuticals hit the 20cm daily limit, with Jiankai Technology, Boji Pharmaceuticals, Bepsis, Chengdu Pioneer, Yaoshi Technology, and Northcoin leading the gains. According to news, on October 15, AstraZeneca and Insitro signed an artificial intelligence drug research and development agreement worth US$1.86 billion, aiming to help find new drugs to treat liver and heart diseases.
Live broadcast 🕐 2026-10-16 09:34
#AI #drug research and development #Live broadcast #AI medical #Chengdu Pioneer
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Afternoon Commentary: The Shenzhen Component Index rose by more than 1% in half 10-16 11:31 [Wind power equipment sector fluctuated and pushed up Tianshun Wind Energy's dai 10-16 11:17 [Military industry sector continues to rise, Zhongke Hisun and more than ten sto 10-16 11:06 [Both the Shanghai Composite Index and the Shenzhen Component Index rose by more 10-16 11:05 [Main Fund Monitoring: Changxin Technology’s Net Buying Exceeded 800 Million] On 10-16 10:57 [IMF President Georgieva: Artificial Intelligence is driving productivity improv 10-16 10:50

Comments

0/500
Captcha (click to refresh)
No comments yet